Radiotherapy for breast cancer in the Republic of Korea typically costs from $17,400 to $25,000. The final price depends on the treatment technology, session count, and hospital tier. In the US, similar procedures cost around $40,000 on average. Patients save around 47% compared to the US. Most Korean medical centers include initial consultations and planning in their base pricing.
Bookimed Expert Insight: Choosing a university-affiliated center like Ewha Womans University Medical Center offers specialized care. This JCI-accredited facility focuses specifically on women-only multidisciplinary oncology. While centers like Samsung Medical Center serve over 2,000,000 patients annually, they maintain presidential standards of care. For the best value, consider Seoul National University Hospital (SNUH). It provides fully digitalized treatment protocols used by the South Korean president. This ensures top-tier technology without the extreme price peaks of some private digital-only boutiques.
Why choose the Republic of Korea for radiotherapy for breast cancer?
Access advanced Radiotherapy for breast cancer solutions in trusted clinics .
| Republic of Korea | Turkey | Austria | |
| Radiotherapy for breast cancer | from $17,360 | from $4,500 | from $10,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Radiotherapy for breast cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Radiotherapy for breast cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Radiotherapy for breast cancer journey.
Day 1
Day 2 - 3
Day 4 - 5
Week 2 - 6
Week 7
Week 8 - 12
Week 13 - 16
Please note that the timeline and procedures may vary based on the individual patient"s condition and response to treatment.
Dr. Choi specializes in heart failure, transplants, and robotic-assisted heart surgeries at Samsung Medical Center.
Dr. Paik Nam-sun is a surgical oncologist at Ewha Womans University Medical Center in Seoul. He is recognized as one of the world's top 100 gastric and breast cancer surgeons. He performed the first breast-conserving surgery in South Korea. Dr. Paik also invented a proprietary stomach cancer technique to reduce reflux disease risk.
Dr. Hyung Seok Park is a breast cancer specialist at Severance Hospital in Seoul. He formerly served as a consultant professor at Anderson University in the United States. Dr. Park specializes in breast cancer surgery and pharmaceutical treatments. He combines surgical expertise with research into hormonal and chemotherapy drugs.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
South Korea’s top hospitals for breast cancer radiotherapy include Samsung Medical Center, Asan Medical Center, and Ewha Womans University Medical Center. These Seoul-based facilities utilize advanced technologies like Novalis and Image-Guided Radiation Therapy (IGRT) within Joint Commission International (JCI) accredited infrastructures to ensure precision oncology care.
Bookimed Expert Insight: While world-ranked centers like Samsung Medical Center serve over 2 million patients annually, they often have significant waiting lists. Data suggests opting for JCI-accredited specialty centers like Ewha Womans University Medical Center provides similar technological standards with more personalized, women-centric care and potentially faster treatment start dates.
Patient Consensus: Patients frequently highlight the availability of 5-week hypo-fractionated courses in Seoul, which successfully reduce fatigue compared to traditional 6-week protocols. Many advise prioritizing stay-integrated facilities like Samsung for better English-speaking coordinator support during daily sessions.
Breast cancer radiotherapy in Korea achieves exceptional success with a 3-year overall survival rate of 98.4% for patients following breast-conserving surgery. The country maintains a 93.6% 5-year relative survival rate for breast cancer, supported by advanced technologies like IMRT and heart-sparing techniques at JCI-accredited Seoul facilities.
Bookimed Expert Insight: While many countries still use conventional 5-week radiation cycles, 89% of Korean practitioners have shifted to hypofractionated radiotherapy. This shorter course offers identical oncologic outcomes but significantly reduces the burden on international patients. Centers like Samsung Medical Center integrate these protocols with Novalis and IGRT technology to ensure presidential-level precision for every patient.
Patient Consensus: Patients report nearly 100% local control for early-stage cases and value the significantly faster treatment access compared to North American or European wait times.
Advanced radiotherapy in South Korea utilizes high-precision technologies like Intensity-Modulated Radiation Therapy (IMRT) and Proton Therapy to target tumors while protecting healthy tissue. Leading Seoul hospitals employ Image-Guided Radiation Therapy (IGRT) and Hypofractionated protocols to improve accuracy and reduce treatment sessions for breast cancer patients.
Bookimed Expert Insight: Data from top-tier facilities like Samsung Medical Center and Severance Hospital shows a shift toward digitalized, error-prevention systems like BESTcare. Choosing clinics with Newsweek World's Best Hospital rankings often ensures access to Novalis systems and RapidArc technology, which complete sessions significantly faster than standard units.
Patient Consensus: Patients frequently highlight that choosing hypofractionation or IMRT in Seoul significantly reduces physical side effects. Many emphasize the importance of verifying English-speaking coordination when discussing complex options like proton therapy for left-sided tumors.
Radiotherapy for breast cancer in the Republic of Korea is generally covered by National Health Insurance for citizens and long-term residents. Coverage typically reaches 70-90% at Joint Commission International-accredited facilities like Severance Hospital. Most patients still face out-of-pocket copayments ranging from $2,200 to $7,400.
Bookimed Expert Insight: While South Korea offers world-class oncology at SNUH and Asan Medical Center, high-demand clinics fill up fast. Patients should verify a hospital carries Grade 1 status through the HIIS app. This designation ensures the highest possible reimbursement rates under the national system.
Patient Consensus: Many patients find total costs 5-10 times cheaper than United States uninsured rates. Most suggest budgeting for a 2-month reimbursement delay and requesting itemized English estimates early.
Patients can safely fly home after external radiotherapy in South Korea. The treatment does not make the body radioactive. Normal contact with others is safe straight away. Most oncologists at JCI-accredited centres like Severance Hospital recommend resting for 7 to 14 days before a long-haul flight to Australia.
Bookimed Expert Insight: South Korea reports a high 91.9% breast cancer survival rate at Seoul National University Hospital. Radiotherapy costs range from $17,400 to $25,000. This is roughly 47% more than Australian averages. Patients should choose Korean clinics for their proton beam therapy and digital safety infrastructure rather than cost savings.
Patient Consensus: Travellers suggest waiting 2 weeks after the final session because fatigue hits hardest then. Redness and skin darkening are temporary. They do not restrict daily activities or flying home to Australia.
Breast cancer radiotherapy in South Korea uses high-precision techniques to protect healthy tissue. These include Intensity-Modulated Radiotherapy (IMRT) and Proton Beam Therapy. Major Seoul-based centres use hypofractionated schedules and deep inspiration breath-hold (DIBH) to reduce heart exposure for left-sided cases. This maintains survival rates above 91%.
Bookimed Expert Insight: South Korean oncology centres like Seoul National University Hospital report breast cancer survival rates of 91.9%. This exceeds many Western benchmarks. This success is tied to the rapid adoption of proton and carbon ion technologies alongside IMRT. IMRT is now the dominant technique in metropolitan Seoul hospitals, replacing traditional 3D-CRT.
Patient Consensus: Patients in the Republic of Korea find the transition to 5-day protocols convenient and appreciate the access to radiation modalities. They suggest confirming the availability of carbon ion therapy directly with specialists during initial consultations.
Hypofractionated radiation is a standard treatment for breast cancer in South Korea. Radiation oncologists at major Seoul centres widely adopt these 3-week schedules. This approach delivers higher daily doses over a shorter period. It provides equivalent results to traditional 5-6 week courses for early-stage breast cancer.
Bookimed Expert Insight: While hypofractionation is common, Korean centres like Seoul National University Hospital report 91.9% breast cancer survival rates. These rates outperform US averages. Patients should confirm if ultra-hypofractionated 5-session protocols are available. These high-volume digital hospitals often integrate real-time CT or MRI tracking. This helps maintain precision during these shorter, intensive courses.
Patient Consensus: Patients find the 15-16 session schedules in South Korea significantly reduce travel time and inconvenience. Cosmetic outcomes and low recurrence rates match those of traditional longer treatments.
Proton therapy for breast cancer is available in South Korea at major specialised facilities, including the Samsung Medical Center. This radiotherapy targets tumours with high precision. It spares the heart and lungs from unnecessary radiation after breast-conserving surgery.
Bookimed Expert Insight: While South Korea is a leader in proton therapy, Samsung Medical Center stands out for Australian patients due to its formal partnership with the Mayo Clinic. This means treatment protocols align with top-tier international standards. This is vital when opting for non-standard radiation therapy.
Patient Consensus: Patients value the digital infrastructure in Seoul hospitals. This makes sharing scans from Australia easier. The presence of 24/7 interpreters and dedicated international coordinators significantly reduces travel stress. This is especially helpful during intensive oncology treatment.
Seoul houses South Korea’s best breast cancer radiotherapy centres, including Samsung Medical Center and Asan Medical Center. These facilities offer technologies like proton beam therapy and image-guided radiation therapy (IGRT). Experts there achieve a 91.9% breast cancer survival rate at Seoul National University Hospital. This exceeds global averages.
Bookimed Expert Insight: Top centres like Samsung and Severance are popular. However, Asan Medical Center stands out for Australian travellers by including free airport transfers and a personal coordinator. This significantly reduces logistical stress and transport costs when navigating Seoul for daily radiotherapy sessions.
Patient Consensus: Patients in Seoul recommend bringing original pathology slides or tumour blocks for local lab confirmation. Medical care is exceptional. However, families often arrange their own private caregivers for bedridden support during treatment.